SHERIDAN, WYOMING – November 10, 2024 – Johnson & Johnson MedTech, a global pioneer in orthopedic technologies, has showcased its advanced portfolio of products and data-driven solutions at the American Association of Hip and Knee Surgeons (AAHKS) 2024 Annual Meeting in Dallas. The company's latest innovations are set to redefine joint reconstruction procedures, enhancing surgical accuracy and patient outcomes.
Aldo Denti, Company Group Chairman, Orthopaedics, Johnson & Johnson MedTech, expressed his enthusiasm for the company's recent achievements, stating, “2024 has been a remarkable year of progress for Johnson & Johnson MedTech, marked by numerous clearances, launches, and strategic collaborations. Most notably, this was the single most successful year for major launches for the VELYS™ Enabling Tech portfolio.”   
Solutions in Motion: A Holistic Approach to Joint Reconstruction

SHERIDAN, WYOMING – November 10, 2024 – Johnson & Johnson is at the forefront of a healthcare revolution, harnessing the power of artificial intelligence (AI) to transform patient care. From enhancing surgical procedures and accelerating drug discovery to personalizing treatments and optimizing the supply chain, AI is integral to Johnson & Johnson's mission to improve the lives of people worldwide.

AI's role in healthcare has evolved significantly since its early conceptualization in the 1950s. While initial limitations hindered its widespread adoption, recent advancements have led to a surge of AI-powered medical devices and applications. "In the next few years, AI is going to play an even bigger role," says Jim Swanson, Executive Vice President and Chief Information Officer at Johnson & Johnson.

Revolutionizing Surgical Procedures

SHERIDAN, WYOMING – November 9, 2024 – AGFA HealthCare, a leading provider of medical imaging solutions, today announced that Groupe santé CHC in Liege, Belgium, has selected the AGFA HealthCare Enterprise Imaging Platform for its entire medical imaging department. The 10-year contract includes supplying, installing, commissioning, and maintaining Enterprise Imaging for Radiology and the Enterprise Imaging VNA. The platform will be used for hospital imaging across various clinic and polyclinic sites, with the entire department performing over 400,000 examinations annually.

Enhancing Efficiency for Better Patient Care

The Enterprise Imaging Platform will deliver high performance and efficiency, enabling Groupe santé CHC's radiologists to perform examinations under optimal conditions.

Dr. François Dister, head of Groupe santé CHC’s medical imaging department, emphasizes the importance of staying at the forefront of medical technology:

SHERIDAN, WYOMING – November 9, 2024 – AGFA HealthCare, a leading provider of diagnostic imaging and healthcare IT solutions, joins the global healthcare community in celebrating International Day of Radiology (IDoR) on November 8th. This annual event commemorates the groundbreaking discovery of X-rays by Wilhelm Röntgen in 1895, a pivotal moment that revolutionized medical diagnosis and treatment.

IDoR serves as a tribute to the invaluable contributions of radiologists, radiographers, and other imaging professionals who play a critical role in patient care. Their expertise and dedication enable the early detection, diagnosis, and management of a wide range of medical conditions, ultimately improving patient outcomes.

SHERIDAN, WYOMING – November 9, 2024 – AGFA HealthCare, a leading provider of enterprise imaging solutions, today announced the successful implementation of its XERO® Exchange Network (XEN) across five NHS Trusts in South Yorkshire and Bassetlaw, UK. This deployment marks a significant milestone in regional healthcare collaboration, enabling seamless image sharing between hospitals, regardless of their existing Picture Archiving and Communication System (PACS) or Radiology Information System (RIS).

The XERO® Exchange Network (XEN) is a groundbreaking solution that facilitates real-time federation across different healthcare organizations. By connecting disparate systems, XEN empowers clinicians with instant access to a patient's complete imaging history, breaking down traditional barriers and streamlining workflows.

SHERIDAN, WYOMING – November 9, 2024 – Shockwave Medical, a Johnson & Johnson MedTech company, has announced encouraging results from its DISRUPT BTK II study, which investigated the use of Intravascular Lithotripsy (IVL) in patients with calcified peripheral lesions below the knee. The study focused on patients with Critical Limb-Threatening Ischemia (CLTI), a severe form of peripheral artery disease (PAD) that can lead to amputation.

PAD affects over 8 million people over 40 in the United States, with CLTI representing the most serious form. It can lead to a 40% major amputation rate within a year and a 50% mortality rate within five years.
The DISRUPT BTK II study enrolled 250 patients with 305 lesions across 38 sites worldwide. The study population included a high percentage of patients with comorbidities such as diabetes, chronic total occlusions (CTOs), and moderate-to-severe calcium, making them particularly challenging to treat.

SHERIDAN, WYOMING – November 9, 2024 – Canon Medical Systems USA, Inc., a leading provider of diagnostic imaging systems and healthcare IT solutions, announced today its participation in the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago, Illinois, from December 1-5.

SHERIDAN, WYOMING – November 9, 2024 – FUJIFILM Corporation is thrilled to announce the global launch of the FUJINON Lens XF500mmF5.6 R LM OIS WR (XF500mmF5.6 R LM OIS WR), a groundbreaking addition to the esteemed XF lens lineup for the X Series mirrorless digital cameras.  This lens redefines the boundaries of super-telephoto photography, offering exceptional optical performance in a remarkably compact and lightweight design.    

"The XF500mmF5.6 R LM OIS WR is a testament to Fujifilm's unwavering commitment to innovation and pushing the boundaries of optical engineering," said a spokesperson for FUJIFILM Corporation. "This lens empowers photographers of all levels of expertise to capture stunning images in the super-telephoto range with unparalleled ease and precision."

Unleashing the Power of Super-Telephoto Photography

SHERIDAN, WYOMING – November 9, 2024 – Fujifilm has announced the launch of the FUJINON XF16-55mmF2.8 R LM WR II lens, a new addition to their X Series of interchangeable lenses.  This lens is designed to provide outstanding image quality in a compact and lightweight body.    

The XF16-55mmF2.8 R LM WR II is the successor to the XF16-55mmF2.8 R LM WR, a large-aperture standard zoom lens and flagship model in the XF lens series.  It is 37% lighter than its predecessor, making it an ideal choice for photographers who need a versatile lens that is easy to carry.    

The lens configuration has been optimized to enhance descriptive performance.  It features an "Aperture Click Switch," a first for the XF lens series, that allows users to choose between a click and de-click setting when operating the aperture ring.  The de-click setting enables smooth brightness changes, which is particularly useful for videographers.    

SHERIDAN, WYOMING – November 9, 2024 – FUJIFILM Corporation is thrilled to announce the launch of the FUJIFILM X-M5, a cutting-edge mirrorless digital camera that redefines the balance between portability and performance. The X-M5, available from mid-November 2024, is the lightest model in the acclaimed X Series, offering exceptional image quality in a compact and lightweight design.    
Weighing approximately 355g, the X-M5 is designed for photographers on the move. It's packed with advanced features, including subject-detection autofocus that leverages AI to track moving subjects like animals and vehicles, and a 6.2K/30P movie recording function for capturing stunning video footage.